Latest News

  • 9-1-1 Opioid Addiction: A Long-Term Problem For A Short-Term Solution

    Diagnostics World Contributed Commentary | Pain is probably the most relatable condition in healthcare. Unfortunately, when the price of relief comes in the form of opioids, too many people get more than just a prescription.

    Nov 3, 2017
  • UCLA, Dana-Farber Cancer Institute, Genestack, And More: News From October 2017

    Diagnostics World | October featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including UCLA, Dana-Farber Cancer Institute, Genestack, and more.

    Nov 2, 2017
  • News And Notes From The Leaders In Biobanking Congress 2017

    Diagnostics World | The 9th annual Leaders in Biobanking Congress was held last week in Nashville, Tennessee. The conference featured lectures from prominent experts in the field of diagnostics and biobanking, and included discussions on topics of clinical research and precision medicine, which often go hand in hand. Here are just a few highlights from the program.

    Nov 1, 2017
  • The Living Heart Comes To The Cloud

    Diagnostics World | For the first time, Dassault Systèmes’s Living Heart Project was used to simulate detailed drug interactions affecting the entire organ function. Now, the Living Heart is available on the cloud.

    Oct 25, 2017
  • DNA Scan For Infants Raises Questions Of Privacy And Discrimination

    CBS News | Genetic counselors in Boston are offering new parents a controversial peek at their baby's future health. It's part of a landmark study that could lead to gene scans for all infants at birth.

    Oct 24, 2017
  • Survey Highlights Microbiome R&D Potential

    Diagnostics World | A recent survey, conducted by Diagnostics World, provides insight into the practices and opinions of those in drug research and development. Qualified members of the R&D industry gave their take on the microbiome’s potential for providing contributions in healthcare, among other things.

    Oct 20, 2017
  • Rethinking The Role Of MMSE In Alzheimer’s Disease Clinical Trials

    Diagnostics World Contributed Commentary | In Alzheimer’s clinical trials, one of the best known and widely-used tests for patient study inclusion is the Mini-Mental State Exam, or MMSE. The main problem with the MMSE is that it is not a valid test of cognitive function.

    Oct 19, 2017
  • Raising Concerns About A Widely Used Test To Measure Fertility

    The New York Times | New research shows that the number of eggs a woman has left doesn’t necessarily predict her ability to conceive naturally.

    Oct 16, 2017
  • Help Wanted: Genetic Guidance

    Diagnostics World | One patient’s near-death experience leads to a thought-provoking encounter with family planning and the booming field of genetic counseling.

    Oct 12, 2017
  • Ovarian Reserve Tests Aren’t A Good Predictor Of Fertility, Study Finds

    STAT | Increasingly popular ovarian reserve tests run the risk of giving women an inaccurate impression of their future chances of having children.

    Oct 10, 2017
  • Pitfalls And Possibilities Of DTC Genetic Testing

    Diagnostics World | One of the overarching concerns about direct-to-consumer genetic testing is that the general public’s access to genetic information could result in misunderstandings or harmful health-related decisions. Researchers are looking actively for ways to make sure that doesn't happen.

    Oct 5, 2017
  • After Blowing The Whistle On Theranos, Tyler Shultz Is Going Back Into Medical Testing

    Forbes | Once Tyler Shultz got to Theranos, he found out that “everyone kind of knew that this thing didn’t actually live up to what we were claiming.” As Shultz starts his own company, Flux Biosciences, his experience with Theranos affects how he talks about his business.

    Oct 4, 2017
  • Fetal Whole Exome Sequencing And Its Potential In Prenatal Diagnosis

    Diagnostics World Podcast | Neeta Vora of University of North Carolina Chapel Hill is featured on this podcast from Cambridge Healthtech Institute in preparation for the 5th annual Advances in Prenatal Molecular Diagnostics conference. Topics include technical challenges and issues surrounding patient counseling, the potential for performing exome sequencing on noninvasively obtained samples, and more.

    Oct 4, 2017
  • Constant Monitoring + AI = Rx For Personal Health

    MIT Technology Review | An audacious Chinese entrepreneur wants to test your body for everything. But are computers really smart enough to make sense of all that data?

    Oct 3, 2017
  • Diagnosing And Treating Depression Could Soon Change Research Advances In Depression

    Diagnostics World | Major depressive disorder (MDD) affects more than 16 million adults in the United States, yet there is still much that is unknown or not clearly understood about the condition. Researchers are investigating the reasons behind the many questions that still linger about how MDD occurs, and a number of recent studies are opening new paths of inquiry that may one day lead to changes in how depression is diagnosed and treated.

    Oct 2, 2017